查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1939278

2026年全球人工器官和醫用仿生學市場報告

Artificial Vital Organs And Medical Bionics Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，人工器官和醫用仿生學市場經歷了顯著成長，預計將從2025年的469.5億美元成長到2026年的510.7億美元，複合年成長率為8.8%。成長要素包括人工器官技術的應用有限、早期仿生設備高成本、對機械器官系統的依賴、器官衰竭的趨勢日益加劇以及醫用仿生設備監管核准的提前。

預計未來幾年，人工重要器官和醫用仿生學市場將保持強勁成長，到2030年市場規模將達到706.7億美元，複合年成長率（CAGR）為8.5%。預測期內的成長要素包括電子和智慧仿生設備的進步、人工器官研發投入的增加、微創移植手術的日益普及、個人化醫療和患者客製化解決方案的發展，以及提供仿生療法的醫院和診所數量的成長。預測期內的主要趨勢包括人工心臟和腎臟設備的日益普及、神經植入與仿生器官的融合度不斷提高、復健和輔助技術的發展、對可客製化患者客製化解決方案的關注，以及臨床試驗和研究性應用的擴展。

預計未來器官衰竭發生率的上升將推動人工重要器官和醫用仿生學市場的成長。器官衰竭是一種嚴重的疾病，指一個或多個器官喪失其基本功能，可能導致嚴重的健康併發症和危及生命的後果。器官衰竭發生率的上升是由糖尿病、高血壓和心臟病等慢性疾病以及遺傳性疾病和易感因素等因素共同導致的。人工重要器官和醫用仿生學透過為器官受損患者提供生命維持和恢復其重要功能來幫助控制器官衰竭。例如，根據總部位於美國的非營利器官捐贈和移植系統－器官取得和移植網路（OPTN）的數據，截至2025年1月，2024年進行的器官移植數量將超過48,000例，比2023年增加3.3%。因此，器官衰竭發生率的上升趨勢正在推動人工重要器官和醫用仿生學市場的成長。

預計未來社會老化將推動人工重要器官和醫用仿生技術市場的成長。老年人口指的是60歲或65歲以上的人。與老齡化相關的健康和生活方式挑戰需要個人化的照護和服務。隨著醫療保健系統的改善和生活水準的提高，預期壽命的延長導致老年人口不斷成長。人工重要器官和醫用仿生技術可以透過替代或增強衰退的生物功能來幫助老年人，提高他們的行動能力、獨立性和整體生活品質。例如，根據美國非營利組織人口研究所（Population Research Institute）2024年1月發布的報告（該機構收集統計數據用於研究和學術用途），預計美國65歲及以上人口將從2022年的5800萬成長到2050年的8200萬，增幅達47%。因此，同期該年齡層占美國總人口的比例將從17%上升到23%。因此，人口老化加劇推動了人造器官和醫用仿生學市場的成長。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球人工器官及醫用仿生學市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧（AI）和自主人工智慧
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 自主系統、機器人與智慧運輸
  • 主要趨勢
    • 人工心臟和腎臟裝置的應用日益普及
    • 神經植入與仿生器官融合技術的進展
    • 復健和輔助科技的發展
    • 專注於可自訂的、特異性患者的解決方案
    • 擴大臨床試驗與研究應用

第5章 終端用戶產業市場分析

  • 醫院
  • 診所
  • 復健中心
  • 研究所
  • 醫療設備製造商

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球人工器官和醫用仿生市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 全球人工器官及醫用仿生學市場規模、對比及成長率分析
  • 全球人工器官和醫用仿生學市場表現：規模和成長，2020-2025年
  • 全球人工器官和醫用仿生學市場預測：規模和成長，2025-2030年，2035年預測

第8章 全球潛在市場規模（TAM）

第9章 市場細分

  • 按類型
  • 人工生命器官，醫學仿生學
  • 透過技術
  • 機械、電子
  • 透過使用
  • 醫院、診所和其他用途
  • 依類型細分：人工生命器官
  • 人工心臟、人工腎臟、人工肝、人工肺、人工胰腺
  • 按類型細分：醫療仿生學
  • 仿生肢體、仿生眼、仿生耳、神經植入、仿生器官

第10章 區域與國家分析

  • 全球人工器官及醫用仿生學市場：區域表現及預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球人工器官及醫用仿生學市場：國家、市場表現及預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章 印度市場

第14章 日本市場

第15章：澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章：西歐市場

第21章英國市場

第22章 德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章 東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章 南美洲市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 人工器官和醫用仿生市場：競爭格局和市場佔有率，2024 年
  • 人工器官與醫用仿生市場：公司估值矩陣
  • 人工器官和醫用仿生學市場：公司概況
    • Abiomed Inc.
    • Abbott Laboratories
    • Medtronic Plc
    • Fresenius Medical Care AG
    • Asahi Kasei Corporation

第37章：其他領先和創新企業

  • Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年人工器官和醫用仿生市場：提供新機會的國家
  • 2030年人工器官與醫用仿生市場：充滿新機會的細分市場
  • 2030年人工器官與醫用仿生市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MAVOM01_G26Q1

Artificial vital organs are engineered devices that replicate the function of essential organs, while medical bionics integrates biological and electronic systems to restore or enhance bodily functions. The primary aim is to sustain life, improve quality of life in cases of severe organ failure, and help recover or enhance lost physical abilities.

The key artificial vital organs and medical bionics consist of artificial vital organs and medical bionics. Artificial vital organs are technologically developed devices that mimic the functions of natural organs such as the heart, lungs, or kidneys to support life in patients experiencing organ failure. These systems may be mechanical or electronic in nature and are commonly used by hospitals, clinics, and other healthcare providers.

Tariffs are impacting the artificial vital organs and medical bionics market by increasing the cost of imported components, such as electronic sensors, mechanical pumps, and specialized biomaterials. Segments like electronic medical bionics and artificial heart devices are particularly impacted, with Asia-Pacific regions including China and India facing higher import duties. This has raised production and procurement costs while causing temporary supply chain disruptions. Positively, tariffs have encouraged local manufacturing, innovation in material sourcing, and investment in domestic production capacities to reduce dependency on imports.

The artificial vital organs and medical bionics market research report is one of a series of new reports from The Business Research Company that provides artificial vital organs and medical bionics market statistics, including artificial vital organs and medical bionics industry global market size, regional shares, competitors with a artificial vital organs and medical bionics market share, detailed artificial vital organs and medical bionics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial vital organs and medical bionics industry. This artificial vital organs and medical bionics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The artificial vital organs and medical bionics market size has grown strongly in recent years. It will grow from $46.95 billion in 2025 to $51.07 billion in 2026 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to limited availability of artificial organ technologies, high cost of early bionic devices, reliance on mechanical organ systems, increasing prevalence of organ failure, initial regulatory approvals for medical bionic devices.

The artificial vital organs and medical bionics market size is expected to see strong growth in the next few years. It will grow to $70.67 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to advancements in electronic and smart bionic devices, rising investment in r&d for artificial organs, increasing adoption of minimally invasive implantation procedures, growth in personalized medicine and patient-specific solutions, expansion of hospitals and clinics offering bionic therapies. Major trends in the forecast period include rising adoption of artificial heart and kidney devices, increasing integration of neural implants and bionic organs, growth in rehabilitation and assistive technologies, emphasis on customizable and patient-specific solutions, expansion of clinical trials and research applications.

The rising prevalence of organ failures is expected to propel the growth of the artificial vital organs and medical bionics market going forward. Organ failure is a serious condition in which one or more organs lose their ability to perform essential functions, resulting in severe health complications and potentially life-threatening outcomes. The increase in organ failures is driven by higher rates of chronic conditions such as diabetes, hypertension, and heart disease, as well as inherited conditions and genetic predispositions that contribute to organ failure. Artificial vital organs and medical bionics help manage organ failure by providing life-sustaining support and restoring critical functions in patients with damaged organs. For instance, in January 2025, according to the Organ Procurement and Transplantation Network, a US-based non-profit scientific organ donation and transplantation system, organ transplants exceeded 48,000 in 2024, representing a 3.3% increase from those performed in 2023. Therefore, the rising prevalence of organ failures is driving the growth of the artificial vital organs and medical bionics market.

The rise in the elderly population is expected to drive the growth of the artificial vital organs and medical bionics market going forward. The elderly population consists of individuals aged 60 or 65 and above who require customized care and services due to aging-related health and lifestyle challenges. The elderly population is increasing due to longer life expectancy supported by improved healthcare systems and better living standards. Artificial vital organs and medical bionics support the elderly population by replacing or enhancing declining biological functions, thereby improving mobility, independence, and overall quality of life. For example, in January 2024, according to a report published by Population Reference Bureau, a US-based non-profit organization responsible for collecting statistical data for research and academic use, the number of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050, reflecting a 47% increase. As a result, this age group's share of the total US population will rise from 17% to 23% during this timeframe. Therefore, the increase in the elderly population is driving the growth of the artificial vital organs and medical bionics market.

Major companies operating in the artificial vital organs and medical bionics market are developing advanced products, such as bionic pancreas systems, to improve patient outcomes and meet the increasing demand for innovative medical solutions. A bionic pancreas is a sophisticated medical device designed to automate blood glucose regulation in individuals with diabetes by replicating the functions of a healthy pancreas. For example, in December 2023, Beta Bionics Inc., a US-based medical technology company, launched the iLet Bionic Pancreas, an autonomous insulin delivery system that simplifies diabetes management by automatically adjusting insulin delivery based on the user's weight. This approach removes the need for healthcare providers to configure complex settings such as insulin-to-carbohydrate ratios, correction factors, or preset basal rates, thereby reducing the burden on both patients and clinicians.

Major companies operating in the artificial vital organs and medical bionics market are Abiomed Inc., Abbott Laboratories, Medtronic Plc, Fresenius Medical Care AG, Asahi Kasei Corporation, Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT, Iwalk Inc., BiVACOR Inc., Nano Retina Inc., Second Sight Medical Products Inc., St. Jude Medical Inc.

North America was the largest region in the artificial vital organs and medical bionics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial vital organs and medical bionics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the artificial vital organs and medical bionics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The artificial vital organs and medical bionics market consists of sales of artificial hearts, artificial kidneys, artificial lungs, artificial pancreas, bionic limbs, cochlear implants, retinal implants, neuroprosthetics. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Vital Organs And Medical Bionics Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses artificial vital organs and medical bionics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial vital organs and medical bionics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial vital organs and medical bionics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Artificial Vital Organs; Medical Bionics
  • 2) By Technology: Mechanical; Electronic
  • 3) By Application: Hospitals; Clinics; Other Applications
  • Subsegments:
  • 1) By Artificial Vital Organs: Artificial Heart; Artificial Kidney; Artificial Liver; Artificial Lungs; Artificial Pancreas
  • 2) By Medical Bionics: Bionic Limbs; Bionic Eyes; Bionic Ears; Neural Implants; Bionic Organs
  • Companies Mentioned: Abiomed Inc.; Abbott Laboratories; Medtronic Plc; Fresenius Medical Care AG; Asahi Kasei Corporation; Boston Scientific Corporation; Biomet Inc.; Terumo Corporation; Edwards Lifesciences Corporation; Otto Bock Healthcare GmbH; Nikkiso Co. Ltd.; Cochlear Ltd.; Ossur; Cirtec Medical; Heartware International Inc.; Berlin Heart GmbH; SynCardia Systems LLC; Ekso Bionics Holdings Inc.; Jarvik Heart Inc.; CARMAT; Iwalk Inc.; BiVACOR Inc.; Nano Retina Inc.; Second Sight Medical Products Inc.; St. Jude Medical Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Artificial Vital Organs And Medical Bionics Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Artificial Vital Organs And Medical Bionics Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Artificial Vital Organs And Medical Bionics Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Artificial Vital Organs And Medical Bionics Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Autonomous Systems, Robotics & Smart Mobility
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Artificial Heart And Kidney Devices
    • 4.2.2 Increasing Integration Of Neural Implants And Bionic Organs
    • 4.2.3 Growth In Rehabilitation And Assistive Technologies
    • 4.2.4 Emphasis On Customizable And Patient-Specific Solutions
    • 4.2.5 Expansion Of Clinical Trials And Research Applications

5. Artificial Vital Organs And Medical Bionics Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinics
  • 5.3 Rehabilitation Centers
  • 5.4 Research Institutions
  • 5.5 Medical Device Manufacturers

6. Artificial Vital Organs And Medical Bionics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Artificial Vital Organs And Medical Bionics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Artificial Vital Organs And Medical Bionics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Artificial Vital Organs And Medical Bionics Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Artificial Vital Organs And Medical Bionics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Artificial Vital Organs And Medical Bionics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Artificial Vital Organs And Medical Bionics Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Artificial Vital Organs And Medical Bionics Market Segmentation

  • 9.1. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Artificial Vital Organs, Medical Bionics
  • 9.2. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Mechanical, Electronic
  • 9.3. Global Artificial Vital Organs And Medical Bionics Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinics, Other Applications
  • 9.4. Global Artificial Vital Organs And Medical Bionics Market, Sub-Segmentation Of Artificial Vital Organs, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Artificial Heart, Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas
  • 9.5. Global Artificial Vital Organs And Medical Bionics Market, Sub-Segmentation Of Medical Bionics, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Bionic Limbs, Bionic Eyes, Bionic Ears, Neural Implants, Bionic Organs

10. Artificial Vital Organs And Medical Bionics Market Regional And Country Analysis

  • 10.1. Global Artificial Vital Organs And Medical Bionics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Artificial Vital Organs And Medical Bionics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Artificial Vital Organs And Medical Bionics Market

  • 11.1. Asia-Pacific Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Artificial Vital Organs And Medical Bionics Market

  • 12.1. China Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Artificial Vital Organs And Medical Bionics Market

  • 13.1. India Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Artificial Vital Organs And Medical Bionics Market

  • 14.1. Japan Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Artificial Vital Organs And Medical Bionics Market

  • 15.1. Australia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Artificial Vital Organs And Medical Bionics Market

  • 16.1. Indonesia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Artificial Vital Organs And Medical Bionics Market

  • 17.1. South Korea Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Artificial Vital Organs And Medical Bionics Market

  • 18.1. Taiwan Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Artificial Vital Organs And Medical Bionics Market

  • 19.1. South East Asia Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Artificial Vital Organs And Medical Bionics Market

  • 20.1. Western Europe Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Artificial Vital Organs And Medical Bionics Market

  • 21.1. UK Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Artificial Vital Organs And Medical Bionics Market

  • 22.1. Germany Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Artificial Vital Organs And Medical Bionics Market

  • 23.1. France Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Artificial Vital Organs And Medical Bionics Market

  • 24.1. Italy Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Artificial Vital Organs And Medical Bionics Market

  • 25.1. Spain Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Artificial Vital Organs And Medical Bionics Market

  • 26.1. Eastern Europe Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Artificial Vital Organs And Medical Bionics Market

  • 27.1. Russia Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Artificial Vital Organs And Medical Bionics Market

  • 28.1. North America Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Artificial Vital Organs And Medical Bionics Market

  • 29.1. USA Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Artificial Vital Organs And Medical Bionics Market

  • 30.1. Canada Artificial Vital Organs And Medical Bionics Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Artificial Vital Organs And Medical Bionics Market

  • 31.1. South America Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Artificial Vital Organs And Medical Bionics Market

  • 32.1. Brazil Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Artificial Vital Organs And Medical Bionics Market

  • 33.1. Middle East Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Artificial Vital Organs And Medical Bionics Market

  • 34.1. Africa Artificial Vital Organs And Medical Bionics Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Artificial Vital Organs And Medical Bionics Market, Segmentation By Type, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Artificial Vital Organs And Medical Bionics Market Regulatory and Investment Landscape

36. Artificial Vital Organs And Medical Bionics Market Competitive Landscape And Company Profiles

  • 36.1. Artificial Vital Organs And Medical Bionics Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Artificial Vital Organs And Medical Bionics Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Artificial Vital Organs And Medical Bionics Market Company Profiles
    • 36.3.1. Abiomed Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Medtronic Plc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Fresenius Medical Care AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Artificial Vital Organs And Medical Bionics Market Other Major And Innovative Companies

  • Boston Scientific Corporation, Biomet Inc., Terumo Corporation, Edwards Lifesciences Corporation, Otto Bock Healthcare GmbH, Nikkiso Co. Ltd., Cochlear Ltd., Ossur, Cirtec Medical, Heartware International Inc., Berlin Heart GmbH, SynCardia Systems LLC, Ekso Bionics Holdings Inc., Jarvik Heart Inc., CARMAT

38. Global Artificial Vital Organs And Medical Bionics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Artificial Vital Organs And Medical Bionics Market

40. Artificial Vital Organs And Medical Bionics Market High Potential Countries, Segments and Strategies

  • 40.1 Artificial Vital Organs And Medical Bionics Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Artificial Vital Organs And Medical Bionics Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Artificial Vital Organs And Medical Bionics Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer